Evaluating the Clinical Effectiveness of "Endotracheal Tube Position Anomaly Alerting System" (NCT06857019) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Evaluating the Clinical Effectiveness of "Endotracheal Tube Position Anomaly Alerting System"
Taiwan200 participantsStarted 2025-02-24
Plain-language summary
The goal of this clinical trial is to determine whether the Endotracheal Tube Position Anomaly Alerting System (ETPAAS) effectively reduces the duration of endotracheal tube malposition in patients admitted to the intensive care unit (ICU). Additionally, the study will assess the clinical impact, usability, and user satisfaction of ETPAAS.
The main questions it aims to answer are:
* Does ETPAAS reduce the duration of endotracheal tube malposition?
* What are healthcare workers' perspectives on the usability and satisfaction of ETPAAS?
Participants will receive standard care, with or without ETPAAS, in the intensive care unit.
Researchers will evaluate the duration of endotracheal tube malposition. Healthcare workers will complete a questionnaire assessing the usability and satisfaction of ETPAAS.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients admitted to the intensive care unit
* At least 18 years old
Exclusion Criteria:
* Patients disagree to participate in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Duration of endotracheal tube malposition
Timeframe: from the initial detection of endotracheal tube malposition to its correction, an estimated average of 48 hours
Trial details
NCT IDNCT06857019
SponsorKaohsiung Medical University Chung-Ho Memorial Hospital